Ashurst and Perkins Coie have advised the underwriters on RIGOL Technologies Co., Ltd’s global offering and listing of H shares on the Main Board of The...
RIGOL Technologies Secures HK$1.14 Billion in Global Hong Kong IPO
Hanx Biopharmaceuticals Completes HK$586 Million Hong Kong IPO
Ashurst has advised ICBC International Capital Limited. Hanx Biopharmaceuticals (Wuhan) Co., Ltd., a China-based biopharmaceutical company, has successfully completed a global offering amounting to HK$586.3 million,...